Specialty Pharma Journal Specialty, Precision & Technology
AstraZeneca, and its global biologics research and development arm MedImmune, today announced a new multi-term agreement with Innate Pharma (Innate), building on an existing collaboration, aimed at accelerating each company’s oncology portfolio and bringing new medicines to patients more quickly. The extended collaboration will enrich AstraZeneca’s immuno-oncology (IO) portfolio with …
Tag Archives: Innate Pharma
October, 2018
February, 2017
-
6 February
Innate’s Checkpoint Inhibitor Fails in Mid-Stage Acute Myeloid Leukemia Trial
Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH) today announces top-line results from the randomized, double-blind, placebo-controlled Phase II trial testing the efficacy of lirilumab as a single agent maintenance treatment in elderly patients with acute myeloid leukemia (AML) in first complete remission (“EffiKIR” trial). The study …
January, 2016
-
11 January
Sanofi and Innate Pharma Partner to Develop New Bispecific NK Cell Engagers
PARIS and MARSEILLE, France, Jan. 10, 2016 (GLOBE NEWSWIRE) — Sanofi and Innate Pharma today announced that they have entered into a research collaboration and licensing agreement to apply Innate Pharma’s new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill tumor cells through …
April, 2015
-
16 April
Sanofi and Innate Pharma Collaborate to Develop Next Generation ADCs
Sanofi is teaming up with Innate Pharma to use its technology for development of new antibody drug conjugates (ADC). Today, France’s Innate Pharma announced that it has entered into a collaboration agreement to apply Innate’s site-specific conjugation technology to the development of new ADC. The companies did not disclose financial …